BioSpace News Archive

U.S. Food and Drug Administration (FDA) granted Regenerative Medicine Advanced Therapy (RMAT) designation for Voyager’s VY-AADC gene therapy treatment for Parkinson’s disease.

Unichem Pharmaceuticals, Inc., “Company”, a Hasbrouck Heights based specialty generic pharmaceutical company, today announced that Scott Delaney has joined the Company as President and Chief Executive Officer - North America for the Company’s parent, Unichem Laboratories Limited, based in Mumbai, India. Mr. Delaney has also been appointed as a member of the Company’s Board of Directors.

The U.S. Food and Drug Administration today approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people 18 years of age and older with diabetes. This is the first FDA-approved CGM system to include a fully implantable sensor to detect glucose, which can be worn for up to 90 days.

Research collaboration with Wageningen University & Research and Harvard University aims to develop methodology for listed equities

MaaT Pharma receives world-wide exclusive license to technology co-developed with hematology and gastroenterology departments of Saint-Antoine Hospital, Paris

Visit Spectrum Booth #32-33 at Compounders on Capitol Hill, Washington, DC, June 23-26

The collaboration will see o2h deploy its expertise in medicinal chemistry to help progress PhoreMost’s portfolio rapidly through the hit-to-lead and lead-optimisation stages of drug discovery.

Agreement marks significant milestone for two of the 29 ANDAs acquired by CASI from Sandoz in January 2018

Alnylam Pharmaceuticals, Inc. announced today that it plans to host its 5th annual series of “RNAi Roundtable” webcasts this summer.

Mr. Gibbs previously served as CFO for Tweed Marijuana Inc., now Canopy Growth Corporation, a Canadian Licensed Producer and one of the largest cannabis producers in the world.